BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3084806)

  • 1. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fluid balance and hemodynamics after perfluorocarbon infusion in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    Crit Care Med; 1985 Dec; 13(12):1015-9. PubMed ID: 3933910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and vascular permeability effects of lipid emulsion in the isolated canine lung lobe.
    Hall JE; Hofman WF; Ehrhart IC
    JPEN J Parenter Enteral Nutr; 1990; 14(4):376-80. PubMed ID: 2119444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures.
    Grote J; Steuer K; Müller R; Söntgerath C; Zimmer K
    Adv Exp Med Biol; 1985; 191():453-61. PubMed ID: 3938602
    [No Abstract]   [Full Text] [Related]  

  • 6. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.
    Castro O; Nesbitt AE; Lyles D
    Am J Hematol; 1984 Jan; 16(1):15-21. PubMed ID: 6695906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorochemical artificial blood as a volume expander in hypoxemic respiratory failure in dogs.
    Light RB; Perez-Padilla R; Kryger MH
    Chest; 1987 Mar; 91(3):444-9. PubMed ID: 3816321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion.
    Gennaro M; Mohan C; Ascer E
    Cardiovasc Surg; 1996 Jun; 4(3):399-404. PubMed ID: 8782946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluosol-DA causes pulmonary hypertension and increased lung lymph flow in unanesthetized sheep.
    O'Brodovich H; Belbeck L; Andrew M; Coates G
    Clin Invest Med; 1985; 8(1):15-21. PubMed ID: 3987115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Fluosol-DA on induction of inhalation anesthesia.
    Chilcoat RT; Gerson JI; Allen FB; Mapleson WW
    Anesth Analg; 1985 Apr; 64(4):405-10. PubMed ID: 3985389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR; Farrar JK; Peerless SJ
    Stroke; 1984; 15(5):829-35. PubMed ID: 6433517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of arachidonate on permeability and resistance distribution in canine lungs.
    Townsley MI; Korthuis RJ; Taylor AE
    J Appl Physiol (1985); 1985 Jan; 58(1):206-10. PubMed ID: 3917991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.